Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06460064
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-04-29
Brief Title:
First-in-human Study to Assess the Safety Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1DSP-0546LP
Sponsor:
Sumitomo Pharma Co Ltd
Organization:
Sumitomo Pharma Co Ltd
Organization Data
Organization:
Sumitomo Pharma Co Ltd
Class:
INDUSTRY
Study ID:
R2411201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sumitomo Pharma Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None